Physician profile
Bruce D Akright
NPI 1679515373
$3,192.03
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,408 · 2020: $247 · 2021: $614 · 2022: $651 · 2023: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $604.07 | 2019-2023 | Lo Loestrin Fe, Liletta |
| Amgen INC. | $418.94 | 2019 | |
| Daiichi Sankyo INC. | $300.48 | 2019-2023 | Injectafer |
| Pfizer INC. | $205.88 | 2019-2023 | |
| Astellas Pharma US INC | $158.08 | 2019-2022 | |
| Intuitive Surgical, INC. | $140.28 | 2019 | |
| Radius Health, INC. | $139.00 | 2019 | |
| Novo Nordisk INC | $130.03 | 2021-2023 | Wegovy |
| Regeneron Pharmaceuticals, INC. | $123.03 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $113.88 | 2019 | |
| Exeltis, USA INC. | $102.13 | 2019-2023 | Slynd |
| Mylan Pharmaceuticals INC. | $100.59 | 2019-2020 | |
| Organon LLC | $82.56 | 2022-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $75.61 | 2019-2022 | |
| Coopersurgical, INC. | $70.31 | 2019-2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $68.55 | 2021-2022 | |
| Hologic Sales and Service, LLC | $53.71 | 2021-2022 | |
| Duchesnay USA Incorporated | $46.75 | 2019 | |
| Therapeuticsmd, INC. | $42.31 | 2019-2022 | |
| Agile Therapeutics, INC. | $31.72 | 2021 | |
| Vertical Pharmaceuticals, LLC | $30.86 | 2019 | |
| Ethicon US, LLC | $29.92 | 2021 | |
| Millicent US INC | $27.39 | 2020 | |
| Avion Pharmaceuticals | $25.22 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.01 | 2021 | |
| Scynexis, INC. | $17.75 | 2022 | |
| Dexcom, INC. | $17.68 | 2021 | |
| Amag Pharmaceuticals, INC. | $11.29 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Akright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.